Web Exclusives
Nutrition & Cancer
By Mu Lin
Web Exclusives – February 8, 2022
Based on current and evolving scientific evidence, the cancer prevention guidelines have been shifting from a nutrient-centric approach to a more holistic approach of diet that is characterized as dietary patterns.
World Cancer Day
Web Exclusives – February 4, 2022
Cancer affects all races, ethnicities, sexual orientations, genders, and nationalities.
Cervical Cancer
By Mu Lin
Web Exclusives – January 13, 2022
Cervical cancer during pregnancy can be successfully managed with a multidisciplinary treatment team and an individualized treatment strategy that optimizes maternal treatment while considering fetal safety.
FDA Approvals, News & Updates
Web Exclusives – December 21, 2021
On November 22, 2021, the FDA approved Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound); from Aadi Bioscience) for adults with locally advanced, unresectable or metastatic malignant perivascular epithelioid-cell tumor (PEComa), a rare type of mesenchymal tumors that can occur in any part of the body.
FDA Approvals, News & UpdatesImmunotherapy
Web Exclusives – December 14, 2021
On August 17, 2021, the FDA accelerated the
approval of Jemperli (dostarlimab-gxly; from
GlaxoSmithKline) injection, an immunotherapy and
a PD-1 inhibitor, for the treatment of all adults with
recurrent (coming back) or advanced mismatch
repair-deficient (dMMR) solid tumors, including
lung cancer, that progressed during or after systemic
therapy and for whom there are no satisfactory alternative treatment options.
COVID-19 & Cancer
Web Exclusives – December 1, 2021
Although we are entering another winter with the ongoing prevalence of the coronavirus, we have come a long way since the initial outbreak. Here are some reasons for patients to be optimistic for the season.
CLL Monthly MinutesLeukemia
Web Exclusives – November 17, 2021
The combination of acalabrutinib, venetoclax, and obinutuzumab has been shown to be an active regimen in previously untreated patients with CLL.
CLL Monthly MinutesLeukemia
Web Exclusives – November 17, 2021
During the first 13 months of the pandemic, COVID-19 continued to result in high hospitalization rates among patients with CLL.
CLL Monthly MinutesLeukemia
Web Exclusives – November 17, 2021
Identifying the risk factors for infection may allow preventive measures to be taken to protect patients.
CLL Monthly MinutesLeukemia
Web Exclusives – November 17, 2021
Oral targeted therapies have revolutionized treatment for patients with CLL but ensuring that they are taken as prescribed is crucial to achieving optimal outcomes.